{"id":"https://openalex.org/W2575679104","doi":"https://doi.org/10.1182/blood.v112.11.5106.5106","title":"Intrinsic Drug Resistance in Multiple Myeloma to Doxorubicin Is Mediated by Soluble Factors","display_name":"Intrinsic Drug Resistance in Multiple Myeloma to Doxorubicin Is Mediated by Soluble Factors","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2575679104","doi":"https://doi.org/10.1182/blood.v112.11.5106.5106","mag":"2575679104"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.5106.5106","doi":"https://doi.org/10.1182/blood.v112.11.5106.5106","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.5106.5106","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Sullivan","raw_affiliation_strings":["H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035721135","display_name":"Jana L. Dawson","orcid":"https://orcid.org/0000-0002-4901-0897","observed_orcids":["https://orcid.org/0000-0002-4901-0897"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jana L. Dawson","raw_affiliation_strings":["H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074142193","display_name":"Elizabeth J. Ciaravino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth J. Ciaravino","raw_affiliation_strings":["H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033566009","display_name":"Joel G. Turner","orcid":"https://orcid.org/0009-0002-6081-3866","observed_orcids":["https://orcid.org/0009-0002-6081-3866","https://orcid.org/0000-0002-2358-6898"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel G. Turner","raw_affiliation_strings":["H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Ctr. & Rsrch. Inst., Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36351603,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"5106","last_page":"5106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.968999981880188},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7409999966621399},{"id":"https://openalex.org/keywords/soluble-factors","display_name":"soluble factors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.9509999752044678},{"id":"https://openalex.org/keywords/topoisomerase-iia","display_name":"topoisomerase IIa","score":0.8450000286102295},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.5809999704360962},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9010000228881836},{"id":"https://openalex.org/keywords/conditioned-medium","display_name":"conditioned medium","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cell-density","display_name":"cell density","score":0.6110000014305115},{"id":"https://openalex.org/keywords/transwell-system","display_name":"transwell system","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.6488893032073975},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.580020546913147},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5393447875976562},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5384568572044373},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.47291454672813416},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46094000339508057},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3901742398738861},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36466267704963684},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.32761284708976746},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30009037256240845},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26520493626594543},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2584555745124817},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18495994806289673},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1698046624660492},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.5106.5106","doi":"https://doi.org/10.1182/blood.v112.11.5106.5106","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.5106.5106","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1521153818","https://openalex.org/W1964478475","https://openalex.org/W1999620129","https://openalex.org/W7098820771","https://openalex.org/W2508216621","https://openalex.org/W1480031276","https://openalex.org/W2132084215","https://openalex.org/W4242768059","https://openalex.org/W4387623690","https://openalex.org/W4296737731"],"abstract_inverted_index":{"Abstract":[0],"Drug":[1],"resistance":[2,171,203,261,280],"continues":[3],"to":[4,68,79,101,120,128,181,185,188,256,281,291,302,326,331],"be":[5,248,257],"a":[6,65,123,157,167,177,212,225],"major":[7],"obstacle":[8],"in":[9,27,135,170,172,195,230,238,265,306],"the":[10,19,35,60,99,102,116,152,173,249,260,266,270,273,286,320],"treatment":[11],"of":[12,38,71,272],"multiple":[13],"myeloma.":[14],"Data":[15],"have":[16],"shown":[17],"that":[18,244,310],"bone":[20],"marrow":[21],"microenvironment":[22,321],"plays":[23],"an":[24,328],"important":[25],"role":[26],"drug":[28,279,316,323],"resistance.":[29],"Whether":[30],"it":[31],"is":[32,49],"mediated":[33],"through":[34],"physical":[36],"interaction":[37],"stromal":[39],"and":[40,56,216],"tumor":[41,57],"cells":[42,92,117,131,148,155,175,186,191,268,288,305,318,325],"or":[43],"by":[44,53,156],"soluble":[45,72,311],"factors,":[46],"this":[47,201,231],"communication":[48],"essential":[50],"for":[51,112,162],"survival":[52],"both":[54],"normal":[55],"cells.":[58,87],"In":[59,88,277],"current":[61],"study":[62],"we":[63,165],"use":[64],"transwell":[66],"system":[67,232],"allow":[69],"passage":[70],"factors":[73,312],"from":[74,98,151,315],"high":[75,106,153,303],"density":[76,81,107,130,143,154,190,304],"(drug":[77,82],"resistant)":[78],"low":[80,129,142,189],"sensitive)":[83],"human":[84],"myeloma":[85],"8226":[86,91],"our":[89],"model,":[90],"translocate":[93],"topoisomerase":[94],"IIa":[95,246],"(topo":[96],"IIa)":[97],"nucleus":[100],"cytoplasm":[103],"when":[104,221,285,300],"at":[105],"(3":[108],"\u00d7":[109,145],"106":[110],"cells/ml)":[111,147],"16":[113,163,274],"hours,":[114],"rendering":[115],"38-fold":[118],"resistant":[119,317],"doxorubicin":[121],"(DOX),":[122],"topo":[124,213,245],"II":[125],"poison,":[126],"relative":[127],"(see":[132,192,233],"column":[133,193],"1":[134,178,194],"graph":[136,196,239],"A":[137],"&":[138,198,236,241],"B":[139],"below).":[140],"When":[141],"(2":[144],"105":[146],"are":[149,313],"separated":[150],"3.0":[158],"micron":[159],"porous":[160],"membrane":[161],"hrs,":[164],"observed":[166,284],"14-fold":[168],"increase":[169],"sensitive":[174,267,287,324],"after":[176],"hr":[179,275],"exposure":[180],"DOX":[182,282],"as":[183,259],"compared":[184],"exposed":[187,290,301],"C":[197,240],"D).":[199],"Moreover,":[200],"increased":[202,329],"was":[204,219,228,283,298],"less":[205],"pronounced":[206],"(2.5":[207],"fold)":[208],"with":[209],"topotecan":[210],"(TPT),":[211],"I":[214],"inhibitor,":[215],"no":[217,296],"effect":[218,297],"seen":[220,299],"cis-platinum":[222],"(CIS":[223],"PLAT),":[224],"non-topo":[226],"drug,":[227],"used":[229],"columns":[234],"2":[235],"3":[237],"D),":[242],"suggesting":[243,309],"may":[247],"specific":[250],"target.":[251],"This":[252],"mechanism":[253],"also":[254],"appears":[255],"time-driven,":[258],"increases":[262],"over":[263],"time":[264],"during":[269],"course":[271],"exposure.":[276],"addition,":[278],"were":[289],"only":[292],"\u201cconditioned\u201d":[293],"media,":[294,308],"but":[295],"fresh":[307],"released":[314],"into":[319],"causing":[322],"acquire":[327],"ability":[330],"evade":[332],"programmed":[333],"cell":[334],"death.":[335],"Figure":[336,337]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-01-26T00:00:00"}